Corporate News     13-Dec-24
CuraTeQ Biologics received recommendation of a marketing authorisation for Zefylti
From European Medicines Agency

CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma,  announced that the Committee for Medicinal Products for Human Use (CHMP) within the European Medicines Agency (EMA) has adopted a positive opinion for Zefylti (BP13, a filgrastim biosimilar) recommending the granting of a marketing authorisation.

Zefylti will be available as 30 MU/0.5 mL and 48 MU/0.5 mL and is intended for the treatment of neutropenia and the mobilisation of peripheral progenitor cells (PBPCs).

Commenting on the update the company spokesperson said, "After receiving the GMP certificate of compliance from the European Medicines Agency (EMA) in November, Zefylti is our first biosimilar to receive a positive opinion from EMA's CHMP. Two more products, our biosimilar versions of pegylated filgrastim (BP14) and trastuzumab (BP02), are currently under review with the EMA, and a biosimilar to bevacizumab (BP01) is under review with the MHRA. We are confident and on track to bring these treatment options to patients next year".

Previous News
  Auro Pharma Q3 PAT slides 10% YoY to Rs 846 crore
 ( Hot Pursuit - 07-Feb-25   12:47 )
  Aurobindo Pharma consolidated net profit declines 9.66% in the December 2024 quarter
 ( Results - Announcements 07-Feb-25   07:32 )
  Board of Aurobindo Pharma approves acquisition of 26% stake in a solar energy company
 ( Corporate News - 06-Feb-25   20:22 )
  Board of Aurobindo Pharma approves acquisition of 80% stake in Tergene Biotech
 ( Corporate News - 06-Feb-25   20:19 )
  Apitoria Pharma's Unit 2 completes USFDA inspection
 ( Corporate News - 28-Jan-25   12:15 )
  Aurobindo Pharma Ltd rises for third straight session
 ( Hot Pursuit - 20-Jan-25   13:06 )
  Aurobindo Pharma to table results
 ( Corporate News - 17-Jan-25   18:01 )
  Aurobindo Pharma Ltd slips for fifth straight session
 ( Hot Pursuit - 08-Jan-25   13:35 )
  Aurobindo Pharma Ltd up for third straight session
 ( Hot Pursuit - 31-Dec-24   13:05 )
  CuraTeQ Biologics receives UK MHRA approval for oncology biosimilar Bevqolva
 ( Corporate News - 23-Dec-24   16:13 )
  Auro Pharma gets UK MHRA nod for cancer drug
 ( Hot Pursuit - 21-Dec-24   15:20 )
Other Stories
  Dhanalaxmi Roto Spinners to convene EGM
  15-Feb-25   20:16
  Sri Lakshmi Saraswathi Textiles(Arni) to convene EGM
  15-Feb-25   20:16
  Roni Households announces board meeting date
  15-Feb-25   19:50
  Compuage Infocom to conduct AGM
  15-Feb-25   18:20
  Flomic Global Logistics to convene board meeting
  15-Feb-25   18:19
  Toyam Sports to announce Quarterly Result
  15-Feb-25   18:19
  Board of Veeram Securities recommends interim dividend
  15-Feb-25   18:19
  ID Info Business Services schedules board meeting
  15-Feb-25   18:19
  National Highways Infra Trust to convene EGM
  15-Feb-25   15:26
  Integrated Personnel Services to conduct EGM
  15-Feb-25   15:26
Back Top